June 9 marks World Women's Reproductive Health Day, highlighting the significance of prioritizing women's health as a crucial aspect in achieving the "Healthy China" strategy. According to the findings from the "2022 Research and Development Trend Analysis on China's Gynecological Drugs Market Status Quo," gynecological diseases have affected over 65% of the global population, with approximately 40% of Chinese women experiencing varying degrees of reproductive tract infections and other related conditions. Furthermore, genitourinary infections worldwide have surpassed an annual incidence rate of 333 million.
Gynecological diseases have a significant impact on the daily lives of women, potentially leading to cervical cancer and other serious conditions. What factors contribute to the development of these diseases?
The human vaginal environment is a complex micro-ecosystem consisting of a dynamic balance between probiotics and conditionally pathogenic bacteria in the vagina and urethra. When influenced by various factors, the delicate balance of flora can be disrupted, allowing pathogenic bacteria to invade and trigger bacterial, fungal, and other types of infections. Some common examples of these pathogens include E. coli, Gardnerella, and Candida albicans.
Women's Reproductive Health Starts with Bacteria
Microprobiotics has introduced a groundbreaking probiotic solution aimed at women's intimate care. Through careful selection of patented and advantageous strains such as Lactobacillus Royale LR08, Lactobacillus Plantarum N13, Lactobacillus Curliforme LCr86, and Lactobacillus Acidophilus LA88, the product aims to enhance the vaginal environment's anti-infective capacity. By improving and rebalancing the healthy vaginal micro-ecology and flora, it effectively promotes women's reproductive health.
Relevant research data
● Lactobacillus plantarum N13 has good antagonism against Candida albicans
Record table of the ability of Lactobacillus plantarum to inhibit Candida albicans
Based on the comparison of 10 Lactobacillus plantarum strains that were more effective in inhibiting Candida albicans, it was found that Lactobacillus plantarum N13 antagonized Candida albicans more.
● Lactobacillus acidophilus LA88 inhibits a variety of vaginal pathogenic bacteria to varying degrees
Lactobacillus acidophilus LA88 demonstrated varying degrees of inhibition against a diverse range of vaginal pathogenic bacteria. This was particularly evident in its significant inhibitory effect on aerobic pathogens such as Pseudomonas aeruginosa. Additionally, it displayed efficacy against typical vaginal anaerobic pathogens like Gardnerella vaginalis and Atopobium vaginalis.
● Lactobacillus acidophilus LA88 significantly inhibits pathogenic bacteria in the mouse vagina
Determination of vaginal flora in mice colony counting table
Lactobacillus acidophilus LA88 was able to significantly inhibit pathogenic bacteria and restore the number of beneficial bacteria in the vagina of mice, and a low concentration of Lactobacillus acidophilus LA88 was able to play a role in the repair of the vaginal environment.
● Lactobacillus curvatus strain LCr86 in combination with Lactobacillus griseus strain LG08 has good inhibition of pathogenic bacteria
Concentrations of Candida albicans in the vagina of mice in each group Table
Lactobacillus curvatus strain LCr86 was able to be used in combination with Lactobacillus griseus strain LG08 for the prevention and treatment of reproductive tract infections with excellent results.
Reinforcing Women's Reproductive Health through Intelligent Manufacturing of Premium Probiotics
As a leading raw material supplier of probiotic strains, Wecare Probiotics has launched a probiotic solution for women's intimate care, which adopts patented advantageous strains of bacteria, scientifically compounded into a highly active and stable formula, which can prevent or treat vaginitis, improve the vaginal environment or rebuild a healthy human vaginal environment, and improve women's vaginal infections from the root of the problem, and it can be applied in the fields of food, pharmaceuticals, and daily chemical products. The product can be used in food, pharmaceuticals, daily chemicals and so on.
The company has consistently adhered to the quality and technology line from start to finish, with a steadfast focus on probiotic strains of science and technology as well as overcoming bottlenecks in industrialization. It has progressed from small-scale pilot testing to large-scale intelligent manufacturing of efficient equipment, establishing industry-leading production facilities and a robust supply chain system for probiotics. From raw materials to finished product testing, the entire process of product processing can be traced back, ensuring the reliable supply of highly stable and highly active probiotic strain raw materials.
The research, production, application, and intelligent manufacturing base off the Wecare Probiotics strain
Data source invention patents:
1, A kind of compound bacterial agent for preventing and controlling reproductive tract infection (ZL202210443994.9)
2, A kind of Lactobacillus acidophilus LA88 improving vaginal environment and its culture method and application (ZL202210489858.3)
3, The use of Lactobacillus plantarum N13 in the preparation of drugs for the prevention and treatment of vaginitis or inhibition of pathogenic bacteria (ZL202210791819.9)